When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.

Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer

The Continuous Update Project (CUP) is an ongoing program that analyzes global research on how diet, nutrition and physical activity affect cancer risk and survival.

A major milestone in cancer research, the Third Expert Report analyzes and synthesizes the evidence gathered in CUP reports and serves as a vital resource for anyone interested in preventing cancer.

AICR has pushed research to new heights, and has helped thousands of communities better understand the intersection of lifestyle, nutrition, and cancer.

Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.

We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.

AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.

AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.

AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.

June 11, 2012 | 4 minute read

For Men's Health Week: Screening for Prevention

Today starts Men’s Health Week and it is actually a great time for cancer prevention for men. You might not think so with all the controversy surrounding PSA testing, but we are making enormous leaps in the ability to detect cancers early when they are most treatable in two of the leading causes of cancer death in men – lung and colorectal.

Colorectal Cancer. We’ve had great screening options for colon and rectal cancers for years. Depending on your preferences and a conversation with your physician as to which test is best for you, there are three evidence-based approaches to colorectal cancer screening: fecal occult blood testing (FOBT or stool test), colonoscopy and flexible sigmoidoscopy.

1. FOBT is a non-invasive test that needs to be done every one to two years. If your FOBT test comes back positive (for blood), your doctor will send you for diagnostic testing, which is done via colonoscopy.

2. Colonoscopy can be both a screening test and a diagnostic test. In a colonoscopy, the entire colon and rectum are examined using a lighted scope. Precancerous and cancerous lesions can be biopsied and removed during the test. Colonoscopy typically requires some form of sedation and a thorough cleansing of the colon.

3. A flexible sigmoidoscopy examines the rectum and lower colon, but not the upper colon.

You can read about the government colorectal screening guidelines on the CDC site.

Some people find the preparation for colonoscopy unpleasant and scientists have been working to find other approaches. A virtual colonoscopy uses x-ray equipment to view the colon and rectum. It is non-invasive and doesn’t require the same preparation as a colonoscopy. However, virtual colonoscopy may not detect smaller abnormal tissue areas or lesions. If a lesion is detected with virtual colonoscopy, a standard colonoscopy is typically required to remove it. Scientists are also working to develop genetic stool tests. In FOBT, the test looks for human blood. In these new tests, the cells from the colon lining that are shed into stool are tested for genetic alterations common in colon cancer. At present, neither test is a recommended screening test by either the National Cancer Institute (NCI) or American Cancer Society (ACS).

Lung Cancer. For years, we didn’t have any evidence-based methods for lung cancer screening. Last year, scientists published a study showing older individuals with a strong smoking history, and thus a strong lung cancer risk, do see a benefit to a low-dose helical CT-based screening. Helical CT (sometimes called spiral CT) takes multiple x-rays of the chest to obtain an image of the entire chest. The National Lung Cancer Screening Trial looked at the effects of this screening tool among current and former heavy smokers with at least a 30-pack-year history.

In the trial, those in the low-dose helical CT arm of the trial had a 20 percent lower risk of lung cancer mortality and a 7 percent lower risk of all-cause mortality than those in the standard chest x-ray arm. The study did not include individuals under age 55 or those who were not heavy smokers.

The National Cancer Institute is still evaluating the trial data to determine its effect on lung cancer screening guidelines. The American Cancer Society issued interim guidelines as a result of the trial finding.

At this point, there is not evidence that non-smokers or light smokers benefit from the screening test – it may in fact do more harm than good, particularly for non-smokers. Forty percent of the trial participants in the CT arm had at least one abnormal scan. These scans lead to additional testing, some of which can be extensive and invasive.

Screening isn’t always the answer, but it is a key part of colorectal cancer prevention and a promising strategy for current and former heavy smokers, though of course, quitting or not starting smoking remains the best way of avoiding lung cancer!

Along with not smoking, other lifestyle choices also play an important role in prevention, such as diet and exercise. You can read more about how to reduce your risk for cancers here.

Dr. Kate Wolin is an Assistant Professor of Public Health Sciences at Washington University School of Medicine and Siteman Cancer Center in St. Louis. She blogs about practical approaches to prevention, wellness and disease management at drkatewolin.com and on Twitter @drkatewolin.

2 comments on “For Men's Health Week: Screening for Prevention

  1. Dennis Laffer on

    The current emphasis for colorectal cancer screening focuses on those tests that accomplish two goals: early detection of cancer at an earlier stage in which treatment may be more straightforward and the survival rate is higher and prevention which is accomplished by removing pre-cancerous polyps. Colonoscopy, performed with the best endoscopic technique and the highest quality bowel preparation can accomplish both of these goals: prevention and early detection. If stool testing for microscopic (occult) blood should be performed utilizing the fecal immunochemical test (FIT) which is specific for human blood and should be performed yearly. The average risk caucasian should begin screening at age 50; for African Americans it should commence at age 45. Risk factors include family history, obesity, smoking, excessive alcohol, and potentially diabetes. Above all, it is important for the patient to be proactive in having the screening performed. It is critical that the endoscopist perform the highest quality exam. Having had stage four colon cancer I can attest to the importance of screening.

    Reply
  2. Dennis Laffer on

    The current emphasis for colorectal cancer screening focuses on those tests that accomplish two goals: early detection of cancer at an earlier stage in which treatment may be more straightforward and the survival rate is higher and prevention which is accomplished by removing pre-cancerous polyps. Colonoscopy, performed with the best endoscopic technique and the highest quality bowel preparation can accomplish both of these goals: prevention and early detection. If stool testing for microscopic (occult) blood should be performed utilizing the fecal immunochemical test (FIT) which is specific for human blood and should be performed yearly. The average risk caucasian should begin screening at age 50; for African Americans it should commence at age 45. Risk factors include family history, obesity, smoking, excessive alcohol, and potentially diabetes. Above all, it is important for the patient to be proactive in having the screening performed. It is critical that the endoscopist perform the highest quality exam. Having had stage four colon cancer I can attest to the importance of screening.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

More From the Blog

Close